194 related articles for article (PubMed ID: 37862074)
1. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study.
Reyniers T; Fiorentino M; Babo SAY; Ouedraogo M; Kanta I; Agbegnigan LE; Rojas D; Anoma C; Dah TTE; Mensah E; Keita BD; Spire B; Vuylsteke B; Laurent C
AIDS Patient Care STDS; 2023 Oct; 37(10):480-488. PubMed ID: 37862074
[TBL] [Abstract][Full Text] [Related]
2. Strategies to improve PrEP uptake among West African men who have sex with men: a multi-country qualitative study.
Reyniers T; Babo SAY; Ouedraogo M; Kanta I; Ekon Agbégnigan L; Rojas D; Eubanks A; Anoma C; Dah TTE; Mensah E; Dembélé Keita B; Spire B; Vuylsteke B; Laurent C
Front Public Health; 2023; 11():1165327. PubMed ID: 37181706
[TBL] [Abstract][Full Text] [Related]
3. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
[TBL] [Abstract][Full Text] [Related]
4. High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.
Paudel K; Gupta S; Gautam K; Wickersham JA; Khati A; Azwa I; Ha T; Shrestha R
J Community Health; 2023 Jun; 48(3):513-521. PubMed ID: 36732459
[TBL] [Abstract][Full Text] [Related]
5. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
[TBL] [Abstract][Full Text] [Related]
6. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
[TBL] [Abstract][Full Text] [Related]
7. Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.
Fu J; Dai Z; Wang H; Si M; Chen X; Wu Y; Xiao W; Huang Y; Yu F; Mi G; Su X
PLoS One; 2023; 18(10):e0293297. PubMed ID: 37856527
[TBL] [Abstract][Full Text] [Related]
8. Reaching a Different Population of MSM in West Africa With the Integration of PrEP Into a Comprehensive Prevention Package (CohMSM-PrEP ANRS 12369-Expertise France).
Eubanks A; Dembélé Keita B; Anoma C; Dah TTE; Mensah E; Maradan G; Bourrelly M; Mora M; Riegel L; Rojas Castro D; Yaya I; Spire B; Laurent C; Sagaon-Teyssier L;
J Acquir Immune Defic Syndr; 2020 Nov; 85(3):292-301. PubMed ID: 32732768
[TBL] [Abstract][Full Text] [Related]
9. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.
Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B;
Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794
[TBL] [Abstract][Full Text] [Related]
10. Socio-behavioral correlates of pre-exposure prophylaxis use and correct adherence in men who have sex with men in West Africa.
Eubanks A; Coulibaly B; Dembélé Keita B; Anoma C; Dah TTE; Mensah E; Kaba S; Lokrou KJ; Ouedraogo FR; Badjassim AMF; Maradan G; Bourrelly M; Mora M; Riegel L; Rojas Castro D; Yaya I; Spire B; Laurent C; Sagaon-Teyssier L;
BMC Public Health; 2022 Sep; 22(1):1832. PubMed ID: 36175860
[TBL] [Abstract][Full Text] [Related]
11. Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men.
Tran NK; Martinez O; Scheim AI; Goldstein ND; Welles SL
AIDS Educ Prev; 2022 Oct; 34(5):365-378. PubMed ID: 36181495
[TBL] [Abstract][Full Text] [Related]
12. A qualitative assessment in acceptability and barriers to use pre-exposure prophylaxis (PrEP) among men who have sex with men: implications for service delivery in Vietnam.
Nguyen LH; Nguyen HLT; Tran BX; Larsson M; Rocha LEC; Thorson A; Strömdahl S
BMC Infect Dis; 2021 May; 21(1):472. PubMed ID: 34030652
[TBL] [Abstract][Full Text] [Related]
13. Rate and Predictors of Ineffective HIV Protection in African Men Who Have Sex with Men Taking Pre-Exposure Prophylaxis.
Eubanks A; Coulibaly B; Dembélé Keita B; Anoma C; Dah TTE; Mensah E; Maradan G; Bourrelly M; Mora M; Riegel L; Rojas Castro D; Yaya I; Spire B; Laurent C; Sagaon-Teyssier L;
AIDS Behav; 2022 Nov; 26(11):3524-3537. PubMed ID: 35469111
[TBL] [Abstract][Full Text] [Related]
14. Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia: findings from a qualitative study.
Bourne A; Cassolato M; Thuan Wei CK; Wang B; Pang J; Lim SH; Azwa I; Yee I; Mburu G
J Int AIDS Soc; 2017 Aug; 20(1):21899. PubMed ID: 28782336
[TBL] [Abstract][Full Text] [Related]
15. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
[TBL] [Abstract][Full Text] [Related]
16. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
[TBL] [Abstract][Full Text] [Related]
17. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
[TBL] [Abstract][Full Text] [Related]
18. Loss to Follow-Up from HIV Pre-Exposure Prophylaxis Care in Men Who Have Sex with Men in West Africa.
Eubanks A; Coulibaly B; Keita BD; Anoma C; Dah TTE; Mensah E; Maradan G; Bourrelly M; Mora M; Riegel L; Rojas Castro D; Yaya I; Spire B; Laurent C; Sagaon-Teyssier L; The CohMSM-PrEP Study Group
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366478
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.
Ahouada C; Diabaté S; Mondor M; Hessou S; Guédou FA; Béhanzin L; Batona G; Gning NN; Zannou DM; Alary M
BMC Public Health; 2020 Aug; 20(1):1267. PubMed ID: 32819335
[TBL] [Abstract][Full Text] [Related]
20. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
